Analyst Reco. Abivax

Equities

ABVX

FR0012333284

Market Closed - Euronext Paris Other stock markets 16:35:03 02/05/2024 BST			After market 20:59:59
13.82 ^EUR	-6.37%		13.86	+0.29%

04-29	Abivax: share price rises as two analysts express optimism	CF
04-29	Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abivax: share price rises as two analysts express optimism	04-29	CF
Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target	04-29	MT
Guggenheim Starts Abivax With Buy Rating, $50 Price Target	04-29	MT
Morgan Stanley Adjusts Price Target on Abivax to $16 From $15, Maintains Equalweight Rating	04-11	MT
Abivax: in green, broker in support	22/08/23	CF
ABIVAX : Oddo BHF maintains its outperform rating	22/08/23	CF
Valneva: up sharply after positive analysis	16/06/23	CF
ABIVAX : Portzamparc downgrades its recommendation	09/06/23	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer